Neural Regeneration Research, 2025 · DOI: https://doi.org/10.4103/NRR.NRR-D-23-01477 · Published: June 1, 2025
Spinal cord injuries often disrupt the corticospinal tract, which is important for motor function. While some regeneration occurs naturally, the mechanisms aren't fully understood. This study focuses on m6A modifications, a common form of epigenetic RNA regulation, and its potential role in corticospinal tract regeneration after spinal cord injury. The research identifies METTL14 and its role in regulating TRIB2 expression, which activates a pathway promoting regeneration. A drug, syringin, is also shown to stabilize METTL14 and improve recovery.
METTL14 is a potential therapeutic target for promoting CST regeneration after SCI.
Syringin, or similar METTL14 stabilizers, could be developed as a treatment to improve neural functional recovery after SCI.
Modulating the TRIB2/MAPK pathway may enhance CST regeneration and functional outcomes in SCI patients.